serw-MX  [xml]  
 


    
 DeCS Categories

C10 Nervous System Diseases .
C10.597 Neurologic Manifestations .
C10.597.606 Neurobehavioral Manifestations .
C10.597.606.150 Communication Disorders .
C10.597.606.150.500 Language Disorders .
C10.597.606.150.500.800 Speech Disorders .
C10.597.606.150.500.800.150 Articulation Disorders .
C23 Pathological Conditions, Signs and Symptoms .
C23.888 Signs and Symptoms .
C23.888.592 Neurologic Manifestations .
C23.888.592.604 Neurobehavioral Manifestations .
C23.888.592.604.150 Communication Disorders .
C23.888.592.604.150.500 Language Disorders .
C23.888.592.604.150.500.800 Speech Disorders .
C23.888.592.604.150.500.800.150 Articulation Disorders .
D02 Organic Chemicals .
D02.241 Carboxylic Acids .
D02.241.081 Acids, Acyclic .
D02.241.081.114 Butyrates .
D02.241.081.114.968 Isobutyrates .
D02.241.081.114.968.500 Fibric Acids .
D02.241.081.114.968.500.500 Clofibric Acid .
D02.241.081.114.968.500.500.195 Clofibrate .
D02.355 Ethers .
D02.355.726 Phenyl Ethers .
D02.355.726.305 Fibric Acids .
D02.355.726.305.500 Clofibric Acid .
D02.355.726.305.500.195 Clofibrate .
D02.455 Hydrocarbons .
D02.455.326 Hydrocarbons, Acyclic .
D02.455.326.146 Alkanes .
D02.455.326.146.100 Alkanesulfonic Acids .
D02.455.326.146.100.050 Alkanesulfonates .
D02.455.326.146.100.050.490 Mesna .
D02.455.426 Hydrocarbons, Cyclic .
D02.455.426.559 Hydrocarbons, Aromatic .
D02.455.426.559.389 Benzene Derivatives .
D02.455.426.559.389.657 Phenols .
D02.455.426.559.389.657.654 Phenyl Ethers .
D02.455.426.559.389.657.654.305 Fibric Acids .
D02.455.426.559.389.657.654.305.500 Clofibric Acid .
D02.455.426.559.389.657.654.305.500.195 Clofibrate .
D02.886 Sulfur Compounds .
D02.886.489 Sulfhydryl Compounds .
D02.886.489.590 Mesna .
D02.886.645 Sulfur Acids .
D02.886.645.600 Sulfonic Acids .
D02.886.645.600.055 Alkanesulfonic Acids .
D02.886.645.600.055.050 Alkanesulfonates .
D02.886.645.600.055.050.500 Mesna .
D03 Heterocyclic Compounds .
D03.383 Heterocyclic Compounds, 1-Ring .
D03.383.742 Pyrimidines .
D03.383.742.698 Pyrimidinones .
D03.383.742.698.253 Barbiturates .
D03.383.742.698.253.650 Phenobarbital .
D03.383.742.698.253.650.700 Primidone .
F01 Behavior and Behavior Mechanisms .
F01.145 Behavior .
F01.145.813 Social Behavior .
F01.145.813.550 Prejudice .
F01.145.813.550.750 Sexism .
F01.145.813.629 Social Discrimination .
F01.145.813.629.750 Sexism .
F01.829 Psychology, Social .
F01.829.595 Prejudice .
F01.829.595.750 Sexism .
J03 Non-Medical Public and Private Facilities .
J03.748 Religious Missions .
K01 Humanities .
K01.844 Religion .
K01.844.777 Religious Missions .
M01 Persons .
M01.427 Missionaries .
SP3 Population Studies in Public Health .
SP3.001 Population .
SP3.001.005 Interpersonal Relations .
SP3.001.005.030 Social Behavior .
SP3.001.005.030.060 Social Problems .
SP3.001.005.030.060.025 Social Discrimination .
SP3.001.005.030.060.025.025 Sexism .
Z01 Geographic Locations .
Z01.107 Americas .
Z01.107.567 North America .
Z01.107.567.875 United States .
Z01.107.567.875.510 Midwestern United States .
Z01.107.567.875.510.515 Missouri .
 
 Terms
 Synonyms & Historicals
Documents
LILACS e MDL
 
Sexism .
Sex Discrimination .
Bias, Gender .
Bias, Sex .
Discrimination, Sex .
Gender Bias .
Sex Bias .
Gender Discrimination .
Gender Intolerance .
Cissexism .
Biphobia .
Female Chauvinism .
Female Chauvinist .
Effeminophobia .
Monosexism .
Heterophobia .
Heterosexism .
Heterosexist .
Misandry .
Misogyny .
Gender Gap .
Prejudice or discrimination based on gender or behavior or attitudes that foster stereotyped social roles based on gender. .
1.00
121967
 
Religious Missions .
Mission, Religious .
Missions, Religious .
Religious Mission .
Missions .
Missions and Missionaries .
Permanent offices or institutions, such as clinics or hospitals, established by religious groups to provide centers for missionary activities, including spreading faith or providing educational, medical, or other assistance. .
0.54
 
Articulation Disorders .
Articulation Disorders, Developmental .
Developmental Articulation Disorders .
Disarticulation Disorders .
Misarticulation .
Phonology Impairment .
Unintelligible Articulation .
Articulation Disorder .
Articulation Disorder, Developmental .
Articulation Disorder, Speech .
Articulation Disorders, Speech .
Articulation, Unintelligible .
Articulations, Unintelligible .
Developmental Articulation Disorder .
Disarticulation Disorder .
Disorder, Disarticulation .
Disorders, Disarticulation .
Impairment, Phonological .
Impairment, Phonology .
Impairments, Phonological .
Impairments, Phonology .
Phonological Impairment .
Phonology Impairments .
Speech Articulation Disorder .
Unintelligible Articulations .
Phonological Impairments .
Speech Articulation Disorders .
MISARTICULATION .
Disorders of the quality of speech characterized by the substitution, omission, distortion, and addition of phonemes. .
0.52
2191642
 
Primidone .
Apo-Primidone .
Liskantin .
Misodine .
Mizodin .
Mylepsinum .
Mysoline .
Primidon Holsten .
Resimatil .
Sertan .
Apo Primidone .
Desoxyphenobarbital .
Primaclone .
An antiepileptic agent related to the barbiturates; it is partly metabolized to PHENOBARBITAL in the body and owes some of its actions to this metabolite. Adverse effects are reported to be more frequent than with phenobarbital. (From Martindale, The Extra Pharmacopoeia, 30th ed, p309) .
0.52
271118
 
Missouri .
State bounded on the east by Illinois and Kentucky, on the south by Arkansas, on the west by Kansas, and on the north by Iowa. .
0.50
07872
 
Missionaries .
Missionary .
Persons sent into an area to evangelize or to perform acts of service, such as medical care, EDUCATION, or SOCIAL JUSTICE. .
0.49
2332
 
Clofibrate .
Athromidin .
Atromid .
Atromid S .
Clofibric Acid, Ethyl Ester .
Ethyl Chlorophenoxyisobutyrate .
Miscleron .
Miskleron .
Chlorophenoxyisobutyrate, Ethyl .
A fibric acid derivative used in the treatment of HYPERLIPOPROTEINEMIA TYPE III and severe HYPERTRIGLYCERIDEMIA. (From Martindale, The Extra Pharmacopoeia, 30th ed, p986) .
0.48
183671
 
Mesna .
ASTA-D 7093 .
MESNA-cell .
Mesnex .
Mesnum .
Mistabron .
Mistabronco .
Mitexan .
Mucofluid .
Sodium 2-Mercaptoethanesulphonate .
UCB-3983 .
Uromitexan .
Ziken .
2 Mercaptoethanesulfonate .
2-Mercaptoethanesulphonate, Sodium .
ASTA D 7093 .
ASTAD 7093 .
MESNA cell .
UCB 3983 .
UCB3983 .
Coenzyme M .
2-Mercaptoethanesulfonate .
A sulfhydryl compound used to prevent urothelial toxicity by inactivating metabolites from ANTINEOPLASTIC AGENTS, such as IFOSFAMIDE or CYCLOPHOSPHAMIDE. .
0.48
121129